Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line Therapy

NCT05221411 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune Hepatitis

Interventions

DRUG: Mycophenolate Mofetil
DRUG: Tacrolimus

Sponsor

Leiden University Medical Center